- This event has passed.
Oct 29 @ 6:00 pm - 8:00 pm
Fran Sverdrup and Dr. Weihl will be presenting. Fran will be speaking about the current state of research (p38 inhibitors for FSHD: Turning off DUX4). Dr. Conrad C. Weihl, MD, PhD, Washington University School of Medicine, Division of Adult Neurology, will be presenting an update on the Fulcrum clinical trial; Phase 2b ReDUX4 trial. Oliver Doerr, from the St. Louis trial site will also be available to answer questions.
Hope to see you there! ~ Marsha Sverdrup, St. Louis Chapter Director
Please contact Marsha at StLouisChapter@fshsociety.org for any questions you may have.
